SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 5th, 2024 • Bio-Path Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 5th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 3, 2024, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 5th, 2024 • Bio-Path Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJune 5th, 2024 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of June 3, 2024, by and between Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SERIES B COMMON STOCK PURCHASE WARRANT bio-path holdings, inc.Security Agreement • June 5th, 2024 • Bio-Path Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledJune 5th, 2024 Company IndustryTHIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 5, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).